|
Panida
Kosrirukvongs, Wipawee Booranapong
Department of
Ophthalmology, Faculty of Medicine Siriraj
Hospital, Mahidol University
Key words:
Bacterial Corneal Ulcer, Topical
Ciprofloxacin
Objective:
To assess topical ciprofloxacin in patients
with moderate severity of suspected
bacterial corneal ulcers.
Study
Design: Randomized, controlled clinical
trial.
Setting:
Inpatient at Siriraj Hospital.
Participants:
All patients with suspected corneal ulcers.
Patients with fungal cause known before
admission and an allergy to any medication,
were excluded.
Intervention:
Topical ciprofloxacin 0.3 per cent or
cefazolin (50 mg/ml) and fortified
gentamicin (14 mg/ml) were given every 15
minutes for the first 6 hours, then every
half hour on the first day, and every hour
while awake till midnight until complete
recovery without staining of fluorescein and
no culture growth.
Main
Outcome Measures: The primary outcomes
were the success rate and duration of the
healing of the ulcer after treatment in each
group.
Results:
Forty-one patients were enrolled. Twelve
(70.6%) of 17 patients in the ciprofloxacin
group were therapeutically successful while
15 (62.5%) of 24 patients in the control
group showed similar outcome without a
statistically significant difference.
However, the mean duration for healing after
treatment was not significantly different
being 14.6 days in the control group and
15.6 days in the ciprofloxacin group. Visual
improvement in the success of the control
and ciprofloxacin groups was 46.7 per cent,
and 66.7 per cent, respectively.
Conclusion:
Treatment with topical ciprofloxacin in
suspected bacterial corneal ulcer should be
considered as an alternative to standard
therapy.
(J Med
Assoc Thai
2000;83:776-82) |